Avid Bioservices, Inc. 10.50% Series E Convertible Preferred Stock
CDMOP
CDMOP was delisted on the 12th of April, 2021.
1 hedge funds and large institutions have $2K invested in Avid Bioservices, Inc. 10.50% Series E Convertible Preferred Stock in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QAM
QCI Asset Management
Pittsford,
New York
|
+$2.02K |
Top Sellers
CDMOP Hedge Fund Activity: Q2 2018 in Review
1 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. 10.50% Series E Convertible Preferred Stock (CDMOP) for Q2 2018, worth a combined $2K.
Buyers outnumbered sellers: 1 fund opened new CDMOP positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was QCI Asset Management, opening a new position worth an estimated $2.02K.
- 1 institutional investor held Avid Bioservices, Inc. 10.50% Series E Convertible Preferred Stock (CDMOP) as of Q2 2018, up from 0 in Q1 2018.
- Funds reported $2K of Avid Bioservices, Inc. 10.50% Series E Convertible Preferred Stock stock for Q2 2018.
- 1 fund opened new Avid Bioservices, Inc. 10.50% Series E Convertible Preferred Stock positions in Q2 2018 and 0 closed out, a net change of +1 holder.
- The largest Avid Bioservices, Inc. 10.50% Series E Convertible Preferred Stock buyer in Q2 2018 was QCI Asset Management, an estimated $2.02K added.
Based on aggregated 13F filings for Q2 2018.